Taboco, Naome .
HRN: 23-03-75 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2023
CEFUROXIME 750MG (VIAL)
11/19/2023
11/25/2023
IV
1.5gm
Q8
SPTAHBSO
Waiting Final Action
11/19/2023
CEFUROXIME 500MG (TAB)
11/19/2023
11/26/2023
PO
500 Mg
BID
S/P TAHBSO
Waiting Final Action